• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Vanda Pharmaceuticals, Inc. (VNDA)

    -NasdaqGM
    12.25 Down 0.48(3.77%) Dec 19, 4:00PM EST
    |After Hours : 12.25 Down 0.00 (0.04%) Dec 19, 5:35PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 33,879   32,727   31,270  
    Cost of Revenue -  129   -  
    Gross Profit 33,879   32,598   31,270  
    Operating Expenses
    Research Development28,190  45,446  28,996  
    Selling General and Administrative24,594  13,882  11,486  
    Non Recurring -   -   -  
    Others1,495  1,495  1,495  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (20,400) (28,225) (10,707)
    Income from Continuing Operations
    Total Other Income/Expenses Net145  561  461  
    Earnings Before Interest And Taxes(20,255)(27,664)(10,246)
    Interest Expense -   -   -  
    Income Before Tax(20,255)(27,664)(10,246)
    Income Tax Expense -   -  (444)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(20,255)(27,664)(9,802)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (20,255) (27,664) (9,802)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (20,255) (27,664) (9,802)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.